Response of the nictitating membrane to prostaglandin E1 and angiotensin.
D000109:Acetylcholine / Q000494:pharmacology; D000804:Angiotensin II / Q000494:pharmacology*; D000818:Animals; D001285:Atropine / Q000494:pharmacology; D002415:Cats; D002794:Choline / Q000494:pharmacology; D004357:Drug Synergism; D004837:Epinephrine / Q000494:pharmacology; D006584:Hexamethonium Compounds / Q000037:antagonists & inhibitors; D009119:Muscle Contraction / Q000187:drug effects*; D009130:Muscle, Smooth / Q000187:drug effects; D009541:Nictitating Membrane / Q000187:drug effects; D010646:Phentolamine / Q000494:pharmacology; D010879:Piperazines / Q000037:antagonists & inhibitors; D011448:Prostaglandin Antagonists; D011453:Prostaglandins / Q000494:pharmacology*; D000644:Quaternary Ammonium Compounds / Q000037:antagonists & inhibitors; D012110:Reserpine / Q000494:pharmacology; D009435:Synaptic Transmission / Q000187:drug effects
D006584:Hexamethonium Compounds; D010879:Piperazines; D011448:Prostaglandin Antagonists; D011453:Prostaglandins; D000644:Quaternary Ammonium Compounds; D000804:Angiotensin II; D001285:Atropine; D012110:Reserpine; D002794:Choline; D000109:Acetylcholine; D004837:Epinephrine; D010646:Phentolamine